Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its R&D investments, including investments done both internally and through M&A.
On Monday, Pfizer Inc (PFE) stock saw a decline, ending the day at $28.93 which represents a decrease of $-0.29 or -0.99% from the prior close of $29.22. The stock opened at $29.22 and touched a low ...
Starboard Value LP Chief Executive Officer Jeffrey Smith said there has been at least $20 billion in value destruction at drugmaker Pfizer Inc., which he admonished for failing to deliver on a ...